Gliomas express high levels of TGF-β, and TGF-β neutralization leads to decreases in brain tumor-infiltrating Tregs, suggesting a role for TGF-β in modulating Tregs [148]. The gene discussed is TGFB1; the disease is central nervous system cancer.